Literature DB >> 7241881

Glomerular hemodynamics in experimental diabetes mellitus.

T H Hostetter, J L Troy, B M Brenner.   

Abstract

Micropuncture studies were performed in three groups of euvolemic male Munich-Wistar rats: 8 control rats, 7 severely hyperglycemic rats made diabetic with streptozotocin (60 mg/kg, i.v.), and 6 moderately hyperglycemic rats made diabetic by the same method but given 2 U of NPH insulin daily. Glucose concentrations at the time of micropuncture study averaged 115 +/- (sem) 10, 565 +/- 12, and 375 +/- 23 mg/dl, respectively. Single nephron GFR (SNGFR) values were significantly lower (28.8 +/- 1.9nl/min) in severely hyperglycemic rats than they were in controls (48.9 +/- 3.8). This reduction in SNGFR was due mainly to a fall in glomerular plasma flow rate ((Q(A)). In contrast, moderately hyperglycemic rats exhibited glomerular hyperfiltration, with SNGFR values averaging 69.0 +/- 8.0 nl/min. This hyperfiltration, with resulted from elevations in values for Q(A) and glomerular transcapillary hydraulic pressure difference (delta P) to levels significantly above control. These alterations in SNGFR in severely hyperglycemic and moderately hyperglycemic rats, relative to controls, were paralleled by changes in whole kidney GFR and mimic the changes in GFR observed in diabetic patients with analogous degrees of hyperglycemia. Measurements of blood volumes in separate groups of control, severely, and moderately hyperglycemic rats revealed equivalent absolute blood volumes in all three conditions and increased blood volumes, relative to body weight, in both groups of hyperglycemic rats. Thus, SNGFR is increased in diabetic rats with moderate hyperglycemia but decreased in those with severe hyperglycemia, and these changes are not simply related to variations in circulating blood volume.

Entities:  

Mesh:

Year:  1981        PMID: 7241881     DOI: 10.1038/ki.1981.33

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  134 in total

1.  Transforming growth factor beta contributes to progressive diabetic nephropathy.

Authors:  W B Reeves; T E Andreoli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

Review 2.  Interventions in chronic renal failure.

Authors:  J R Curtis
Journal:  BMJ       Date:  1990-09-29

Review 3.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Evening primrose oil reduces urinary calcium excretion in both normal and hypercalciuric rats.

Authors:  I Tulloch; W S Smellie; A C Buck
Journal:  Urol Res       Date:  1994

5.  Are the 'second generation' oral hypoglycemic agents really different?

Authors:  E F Pfeiffer
Journal:  Acta Diabetol Lat       Date:  1984 Jan-Mar

6.  Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M Wiseman; G Viberti; D Mackintosh; R J Jarrett; H Keen
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

7.  Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats.

Authors:  N Yagihashi; N Nishida; H G Seo; N Taniguchi; S Yagihashi
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

8.  Effect of antihypertensive drugs on glomerular hyperfiltration and renal haemodynamics. Comparison of captopril with nifedipine, metoprolol and celiprolol.

Authors:  J Böhler; A Becker; P Reetze-Bonorden; R Woitas; E Keller; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 9.  The renal vascular response to diabetes.

Authors:  Pamela K Carmines
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

10.  Evaluation of the presence of circulating immune complexes and their relationship to glomerular IgG deposits in streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.